Squire Patton Boggs has advised Intersurgical, a global leader in the design, manufacture and supply of high-quality medical devices for anaesthesia and respiratory care, on the acquisition of the Acute Care and Interventional Urology businesses of Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, for US$530 million. The transaction is expected to be completed in the second half of 2026, subject to customary regulatory approvals and closing conditions.
The international Squire Patton Boggs team advising Intersurgical was led by Corporate partner David Milne, with partner support from Andrew Slucky, Patrick Brooks, Diarmuid Ryan and Mitch Thompson, assisted by Laura Aber, Josh Astill-Headley, Athina Maneli and James Mosley, and supported by multi-disciplinary legal specialists in the UK and US.
